Few Receive Meds for Opioid Use Disorder After Nonfatal Overdose
By Elana Gotkine HealthDay Reporter
MONDAY, June 17, 2024 -- In the 12 months after a nonfatal overdose, few Medicare beneficiaries receive medications for opioid use disorder (MOUD) or fill a naloxone prescription, according to a study published online June 17 in JAMA Internal Medicine.
Christopher M. Jones, Pharm.D., Dr.P.H., from the Substance Abuse and Mental Health Services Administration in Rockville, Maryland, and colleagues examined the receipt of MOUD, naloxone, and behavioral health services in the 12 months after an index nonfatal drug overdose in a cohort study. The cohort included 136,762 Medicare beneficiaries who experienced an index nonfatal drug overdose in 2020.
The researchers found that 17.4 percent of beneficiaries experienced at least one subsequent nonfatal drug overdose in the 12 months after their index nonfatal overdose and 1.0 percent died of a fatal drug overdose. Overall, 72.2 percent of fatal drug overdoses involved opioids. In the 12 months after the index nonfatal drug overdose, 4.1 and 6.2 percent received any MOUD and filled a naloxone prescription, respectively. Reduced adjusted odds of fatal drug overdose in the 12 months after the index nonfatal drug overdose were seen in association with filling a naloxone prescription (adjusted odds ratio [aOR], 0.70), each percentage of days receiving methadone or buprenorphine (aORs, 0.98 and 0.99, respectively), and receiving behavioral health assessment or crisis services (aOR, 0.25).
"These findings underscore the need to increase the uptake of evidence-based care after a nonfatal drug overdose," the authors write.
One author disclosed ties to General Electric, 3M, and Pfizer.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.